Cargando…

Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling

Detalles Bibliográficos
Autores principales:	Cutler, Jevon A., Udainiya, Savita, Madugundu, Anil K., Renuse, Santosh, Xu, Yaoyu, Jung, Jaehun, Kim, Kwang Pyo, Wu, Xinyan, Pandey, Akhilesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934410/ https://www.ncbi.nlm.nih.gov/pubmed/31399640 http://dx.doi.org/10.1038/s41375-019-0535-4

Ejemplares similares

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer
por: Renuse, Santosh, et al.
Publicado: (2021)

The phosphatase UBASH3B/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis
por: Mian, Afsar A., et al.
Publicado: (2019)

Quantitative Proteomics Reveals that the OGT Interactome Is Remodeled in Response to Oxidative Stress
por: Martinez, Marissa, et al.
Publicado: (2021)

Phosphotyrosine profiling of human cerebrospinal fluid
por: Sathe, Gajanan, et al.
Publicado: (2018)

Mapping the micro-proteome of the nuclear lamina and lamina-associated domains
por: Wong, Xianrong, et al.
Publicado: (2021)

Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts
por: Wu, Xinyan, et al.
Publicado: (2018)

Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts
por: Wu, Xinyan, et al.
Publicado: (2018)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
por: Kawakami, Shohei, et al.
Publicado: (2022)

Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases
por: Selvan, Lakshmi Dhevi Nagarajha, et al.
Publicado: (2018)

Integrated Transcriptomic and Proteomic Analysis of Primary Human Umbilical Vein Endothelial Cells
por: Madugundu, Anil K., et al.
Publicado: (2019)

BCR: a new target in resistance mediated by BCR/ABL-315I?
por: Haberbosch, Isabella, et al.
Publicado: (2016)

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins
por: You, Liangshun, et al.
Publicado: (2016)

Expanding the Diversity of Allosteric Bcr-Abl Inhibitors
por: Deng, Xianming, et al.
Publicado: (2010)

An In-House Method for Molecular Monitoring of BCR-ABL
por: Sercan, Hakkı Ogün, et al.
Publicado: (2012)

Depression of oncogenecity by dephosphorylating and degrading BCR-ABL
por: Gao, Miao, et al.
Publicado: (2016)

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
por: Zhou, Liang L., et al.
Publicado: (2008)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
por: Zeng, Dachuan, et al.
Publicado: (2022)

Functional phosphoproteomic analysis reveals cold-shock domain protein A to be a Bcr-Abl effector-regulating proliferation and transformation in chronic myeloid leukemia
por: Sears, D, et al.
Publicado: (2010)

Systematic identification of ALK substrates by integrated phosphoproteome and interactome analysis
por: Adachi, Jun, et al.
Publicado: (2022)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
por: Maletzke, Saskia, et al.
Publicado: (2022)

UBASH3B-mediated silencing of the mitotic checkpoint: Therapeutic perspectives in cancer
por: Krupina, Ksenia, et al.
Publicado: (2017)

Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-Induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice
por: Chen, Yaoyu, et al.
Publicado: (2009)

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1(T315I) and BCR-ABL1(T315I-E255K)
por: Mian, Afsar Ali, et al.
Publicado: (2021)

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
por: Baum, Karina J, et al.
Publicado: (2008)

Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus
por: Huang, Zheng-Lan, et al.
Publicado: (2013)

IGF-IR determines the fates of BCR/ABL leukemia
por: Xie, Jingjing, et al.
Publicado: (2015)

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
por: Polillo, Marialuisa, et al.
Publicado: (2015)

Bcr-Abl tyrosine kinase inhibitors- current status
por: Mughal, Anum, et al.
Publicado: (2013)

Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia
por: Kim, Jaeseung C., et al.
Publicado: (2023)

The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia
por: Rafiei, Anahita, et al.
Publicado: (2015)

Targeting the PTP1B‐Bcr‐Abl1 interaction for the degradation of T315I mutant Bcr‐Abl1 in chronic myeloid leukemia
por: Elgehama, Ahmed, et al.
Publicado: (2022)

A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples
por: Mangalaparthi, Kiran K., et al.
Publicado: (2021)

Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides
por: Maus, Anthony, et al.
Publicado: (2021)

Correction: A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples
por: Mangalaparthi, Kiran K., et al.
Publicado: (2022)

UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1
por: Jin, Ketao, et al.
Publicado: (2017)

T Cell Receptor Genotype and Ubash3a Determine Susceptibility to Rat Autoimmune Diabetes
por: Mordes, John P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_epaul9jcc572qveamsbcki8k2i